However, the Company and the Directors cannot make any assurance...

First 10 Last

Share
Profile

Follow
riverbrae

2,515 Posts.

26/08/14

23:24

Post #: 13876935
Share

Originally posted by riverbrae ↑

Directors' recommendation and intention
Having regard to all the considerations discussed in this Notice, your Directors consider that, in the absence of a superior proposal, the expected advantages of the Entitlement Issue outweigh its potential disadvantages and risks.
Shareholders should be advised that if the Resolution is not passed by the required majority and the Entitlement Issue does not proceed, the Company may be unable to meet its payment obligations to its creditors. The failure to implement the Entitlement Issue and pay creditors may have significant implications for the Company, empowering creditors to take enforcement action, including appointing an administrator and the Company may become insolvent. In the option of the Board, the implementation of the Entitlement Issue significantly reduces this risk for the Company

IT IS MY PERSONAL OPINION, HAVING ,ALONG WITH THOUSANDS OF OTHERS LOST A VERY CONSIDERABLE INVESTMENT IN THIS COMPANY ,THAT PUTTING IT INTO ADMINISTRATION WOULD BE IN SHAREHOLDERS BEST INTERESTS.
IT WOULD REMOVE AT LEAST ONE BADLY PERFORMING COMPANY FROM THE ASX.

RB

Expand

However, the Company and the Directors cannot make any assurance as to the price at which Shares will trade after the Entitlement Issue is completed.

IMO that is a correct assessment.
RB

CCC Price at posting: 2.0¢ Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

However, the Company and the Directors cannot make any assurance...

Top Stories

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News